Effectiveness of Pharmacological Treatments in Pediatric Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis - Top-Institutions - MDSpire

Effectiveness of Pharmacological Treatments in Pediatric Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis

  • By

  • Shehab Yaser

  • Hatem Yaser

  • Hazem E. Mohammed

  • Mohamed Nasser

  • Mohamed Khalafalla Darwish

  • Mohamed E. Haseeb

  • Anas Hussein Heiba

  • Mohamed Mabrouk Ghonaim

  • Heba Aboeldahab

  • Zeyad Bady

  • December 8, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatric Hepatology
    • Pediatric Gastroenterology
    • Metabolic Liver Disease

  • #2

    Baylor College of Medicine / Texas Children's Hospital
    Baylor College of Medicine / Texas Children's Hospital

    Houston, TX

    Key Differentiators

    • Pediatric Hepatology
    • Pediatric Gastroenterology
    • Metabolic Disorders

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Hepatology
    • Pediatric Gastroenterology
    • Clinical Research

  • #4

    University of California, San Diego (UCSD) - Rady Children's Hospital
    University of California, San Diego (UCSD) - Rady Children's Hospital

    San Diego, CA

    Key Differentiators

    • Pediatric Hepatology
    • Metabolic Liver Disease
    • Clinical Trials

Original Source(s)

Effectiveness of Pharmacological Treatments in Pediatric Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis

  • by Shehab Yaser, Hatem Yaser, Hazem E. Mohammed, Mohamed Nasser, Mohamed Khalafalla Darwish, Mohamed E. Haseeb, Anas Hussein Heiba, Mohamed Mabrouk Ghonaim, Heba Aboeldahab, Zeyad Bady

  • December 8, 2025

Related Content

Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

To Fix or Not to Fix: Effect of Gastropexy on Esophageal Manometric Values Post Laparoscopic Sleeve Gastrectomy

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.